Form 4: Medpace Holdings Director Brian T. Carley Reports Stock Transaction
SEC Form 4 Filing
Director Brian T. Carley reports a transaction involving Medpace Holdings, Inc. common stock and restricted stock units.
Summary
- On March 31, 2025, Brian T. Carley, a director of Medpace Holdings, Inc., reported a transaction involving the company's securities.
- Carley acquired 63 shares of common stock through the vesting of restricted stock units.
- Following the transaction, Carley directly owns 26,095 shares of Medpace Holdings, Inc.
- The reported transaction involved the vesting of restricted stock units granted on November 29, 2024, which vest in four equal installments.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, indicating a neutral sentiment.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their transactions in the company's stock.
Stakeholder Impact
- The transaction provides shareholders with insight into the actions of a company director.
Key Dates
| Date | Description |
|---|---|
| 11/29/2024 | Reporting Person was granted 249 restricted stock units |
| 03/31/2025 | Transaction Date: Acquisition of 63 shares of common stock through vesting of restricted stock units. |
| 03/31/2025 | First vesting date of restricted stock units. |
| 06/30/2025 | Second vesting date of restricted stock units. |
| 09/30/2025 | Third vesting date of restricted stock units. |
| 12/31/2025 | Fourth vesting date of restricted stock units. |
| 04/02/2025 | Date of Form 4 filing. |
Keywords
Form 4, Medpace Holdings, Brian T. Carley, Stock Transaction, Restricted Stock Units, Director
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.